The latest FDA approved technology in Dry Eye Disease Treatment

Optilight by Lumenis

Intense Pulse Light treatment (IPL)

OptiLight by Lumenis is a light-based, non-invasive treatment done in the area below the eyes to manage dry eye. The first and only IPL FDA-approved for dry eye management. The treatment is safe, gentle, and backed by more than 20 clinical studies.  OptiLight uses precise pulses of light to reduce the inflammation that is typically associated with dry eye disease, improve tear break-up time, and increase meibomian gland functionality. 

This application can significantly relieve dry eye indicators and has a multi-factorial effect, including:

• Decreasing demodex and bacteria around the eyelids.
• Closing off blood vessels that release inflammation
• Inhibits the release of proinflammatory mediators
• Reinvigorates the meibomian glands and normalizes their secretions
• Allowing healthy oil production that protects your tears

It works to control the inflammatory process and to stop the vicious cycle of inflammation and to reduce the need for medications. IPL treats:

• Ocular rosacea
• Meibomian gland dysfunction
• Inflammatory dry eye
• Ocular surface disease

Treating your dry eye sometimes turns into treating yourself.  IPL helps reverse the signs of aging by stimulating collagen production for younger-looking eyes.  It has been used in dermatology for many years for skin rejuvenation.  Often referred to as a “photofacial,” the treatment can be used to erase mild sun damage, age-spots, freckles or irregular pigmentation on the eyes, face and neck.

Optilight is performed in a series of 3-4 treatment sessions and sometimes used in combination with radio frequency as discussed below.

_________________________________________________________